Show
Sort by
-
Identifying and validating DNA methylation biomarkers: the example of neuroblastoma
-
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
-
- Journal Article
- A1
- open access
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.
-
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
-
Promoter methylation analysis identifies prognostic methylation biomarkers in neuroblastoma
-
- Journal Article
- A1
- open access
The microRNA body map : dissecting microRNA function through integrative genomics
-
miRNA Expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples
-
- Journal Article
- A1
- open access
Measurable impact of RNA quality on gene expression results from quantitative PCR
-
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles
-
An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours